Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Asthma guidelines suggest that therapy can be reduced once asthma is controlled. Despite these recommendations, asthmatic patients are seldom stepped down in clinical practice, and questions remain about when and how to reduce asthma...
Main Authors: | Papi Alberto, Nicolini Gabriele, Crimi Nunzio, Fabbri Leonardo, Olivieri Dario, Rossi Andrea, Paggiaro Pierluigi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/13/1/54 |
Similar Items
-
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
by: Price DB, et al.
Published: (2022-02-01) -
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
by: Price DB, et al.
Published: (2022-03-01) -
Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01) -
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
by: Tsan-Ming Huang, et al.
Published: (2020-09-01) -
Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)